Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 42 / 71

12.5 %The prevalence of overweight/obesity was 12.5% in nursery and primary school children in urban Cameroon.

Camerounoverweight/obesitypublished 2017BMC obesityeurope_pmcdocument of 5 observationsDOI 10.1186/s40608-017-0146-4

Active case search data from June 2026 revealed a high burden of unreported suspected VPDs, primarily measles, concentrated in the East and Southern Africa Block (Mozambique, Malawi, Tanzania, Ethiopia, Kenya, Zambia, and Madagascar), in the DRC-Angola Block (DRC and Angola), in the West Block (Benin, Togo and Guinea), and in the Lake Chad Basin (Nigeria, Chad, Cameroon and Central African Republic).

Angola · Bénin · Cameroun · Éthiopie · Guinée · Kenya · Madagascar · Malawi · Mozambique · Nigeria · RDC · Tanzanie · Tchad · Togo · Zambierougeole · VPDsobserved June 2026WHO Africadocument of 17 observations

74 %74% of patients with type 2 diabetes had poor glycemic control.

Cameroundiabète de type 2published 2015Diabetes research and clinical practiceeurope_pmcdocument of 5 observations

36.1 %Contrary to Cameroonian doctors who considered termination of an affected pregnancy (TAP) for SCD in 36.1%, the majority of parents (62.5%) with affected children accepted TAP in principle.

Cameroundrépanocytosepublished 2015Public health genomicseurope_pmcdocument of 6 observations

12.1 %The age-standardized prevalence of hypertension was 12.1% in urban women in Cameroon.

Camerounhypertension artériellepublished 1998International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/27.2.181

21.8 %A male chimpanzee (Cam155), 1.5 years old, showed a weight loss of 21.8% from August 2009 to January 2010 (16 to 12.5 kg).

CamerounSIVcpzobserved August 2009 to January 2010published 2011RetrovirologyOpenAlexdocument of 4 observationsDOI 10.1186/1742-4690-8-4

0.44 proportionThe T allele frequency was significantly higher in the diabetic group (0.44) than in the control group (0.17).

Cameroundiabète de type 2published 2015Clinical and translational medicineeurope_pmcdocument of 2 observations

43.1 %47 out of 109 patients (43.1%) were predicted to express the RH10 (V) low-frequency antigen.

CameroundrépanocytoseHAL · Unilimdocument of 45 observations

2 %2.0% of the included HIV-infected patients had diabetes.

Cameroundiabète (non précisé)published 2017Lipids in health and diseaseeurope_pmcdocument of 7 observations

-0.63 mmol/LThe difference in 2-h glucose between those in the highest tertile of plasma Zn compared to the lowest was -0.63 mmol/L.

Cameroundiabète de type 2published 2023The British journal of nutritioneurope_pmcdocument of 5 observations

Cameroon and Gabon are predicted to have Laverania infection probability dropping between June and August.

Cameroun · GabonLaveraniaHAL · Unilimdocument of 24 observations

11.4 %A significant reduction in HbA1c was observed after 1 year, from 11.4%±2.7% to 8.7±2.4%.

Cameroundiabète de type 1published 2017BMJ open diabetes research & careeurope_pmcdocument of 7 observations

The prevalence of hypertension in Cameroon increased by twofold to fivefold between 1994 and 2003.

Camerounhypertension artérielleobserved 1994 to 2003published 2010Journal of epidemiology and community healtheurope_pmcdocument of 3 observationsDOI 10.1136/jech.2008.086355

0 %In Yaoundé, the capital city of Cameroon, the prevalence of WHO-defined transmitted HIV-1 drug resistance mutations (DRMs) among ART-naive individuals was 0.0% in 1996–1999.

CamerounVIH/sidaobserved 1996–1999published 2011AIDS (London, England)europe_pmcdocument of 5 observationsDOI 10.1097/qad.0b013e32834bbbe9

3.1 %Among 458 patients who initiated antiretroviral therapy in rural district hospitals in Cameroon between 2006 and 2008, 14 (3.1%) classified at WHO clinical stage 4 had a CD4 count above 350 cells/mm³.

CamerounVIH/sidaobserved 2006-2008published 2010Tropical medicine & international health : TM & IHeurope_pmcdocument of 7 observations

9.2 odds_ratioThere was an association between diabetes and hypertension (OR 9.2 [95% CI: 5.0–16.9]).

Cameroundiabète (non précisé) · hypertension artériellepublished 2017BMC health services researcheurope_pmcdocument of 7 observationsDOI 10.1186/s12913-017-2197-0

58 %58 % des cas de paludisme surviennent dans les 20 % des pays les plus pauvres de la population mondiale.

CamerounpaludismeHAL · Unilimdocument of 98 observations

6.4 %Of 47 patients with type 1 diabetes, 3 (6.4%) had IA2 autoantibodies.

Cameroundiabète de type 1 · IA2 autoantibodiespublished 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument of 10 observations

19.5 %Based on body mass index, 19.5% of urban women in Cameroon were obese.

Camerounobésitépublished 2006BMC public healtheurope_pmcdocument of 6 observations

38.5 %38.5% of HIV-infected ART-naïve patients had insulin resistance.

Camerouninsulin resistancepublished 2017Lipids in health and diseaseeurope_pmcdocument of 7 observations

2.5 %D’ici 2027, le Ministère de la Santé Publique du Cameroun vise une réduction du taux de prévalence du paludisme chez les enfants de 6 à 59 mois à 2,5 %.

Camerounpaludismeobserved 2027HAL · Unilimdocument of 98 observations

17 patientsProximal muscle weakness was noted in all 17 Cameroonian Duchenne Muscular Dystrophy patients.

CamerounDuchenne Muscular Dystrophypublished 2020Molecular genetics & genomic medicineeurope_pmcdocument of 11 observations

56.7 yearsThe mean age of type 2 diabetes patients in the study was 56.7 years.

Cameroundiabète de type 2published 2012Cardiovascular journal of Africaeurope_pmcdocument of 11 observations

8.1 %In the Monatélé Health District, 7 of the 78 surveyed communities had a prevalence of suspected cases of epilepsy exceeding 5.0%, with the highest value being 8.1% in Levem.

CamerounépilepsieHAL · Unilimdocument of 53 observations

11.1 %Over 5,504 person-years, 414 patients died (11.1%).

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.